52North

📍 Cambridge, United Kingdom🗓 Founded 2018👥 27 employees💰 Last funded Jan 2025
Medical Equipment Manufacturing🌐 52north.health
Website LinkedIn
52North is a medical technology company on a mission to make urgent care pathways safer and more effective. Awarded breakthrough status for its first product Neutrocheck® by the UK Government in 2024, 52North builds in vitro diagnostic and digital solutions to transform patient journeys in urgent care. Its award-winning, multidisciplinary team is based in Cambridge, UK. 52North is backed by leading UK and US hospital venture funds, Meridian Health Ventures and Cedars-Sinai Intellectual Property company, and other partners, including the University of Cambridge and Macmillan Cancer Support.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in 52North?
52North has 1 investors on record on gritt.io and 1 late-stage investors.
When did 52North last raise funding?
The most recent investment in 52North recorded on gritt.io was in January 2025.
When was 52North founded?
52North was founded in 2018.
What industry is 52North in?
52North operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is 52North based?
52North is headquartered in Cambridge, United Kingdom.